Terumo launches VenoJect II RAPClot blood collection tubes in Japan in partnership with Q-Sera
Thursday, March 12, 2026
2 min read
Canonical SourceJapan
Summary Only
What Changed
Terumo Corporation has launched VenoJect II RAPClot blood collection tubes in Japan, incorporating Q-Sera's Rapclot technology to expedite blood clotting.
Sigvera Intelligence
Source Trust:Discovery
Source Report
Terumo Corporation launched its VenoJect II RAPClot blood collection tubes in the Japanese market, which use Q-Sera's patented Rapclot technology to accelerate blood clotting.
Industry Context
Healthtech & Biotech
Where this signal fits in the broader landscape.
115 industry signalsProduct Launch
Source Verification
Verified from official source
Publisher—
Publication DateMar 12, 2026
Source ClassVerified Canonical
Signal Timeline
First ReportedMar 12, 2026
IndexedMar 12, 2026
PublishedMar 12, 2026
https://www.globenewswire.com/news-release/2026/02/19/3240831/0/en/Q-Sera-announces-the-first-launch-of-blood-collection-tubes-using-its-patented-Rapclot-technology-in-Japan-opening-opportunities-for-additional-global-partnerships.html
Read Full SourceGet cross-language signal intelligence
Get curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
My Notes
Sign in to save notes on signals.
Sign In